Overview
- 37 inspections across 33 sites are on record.
- 11 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-03-28.
At a glance
Inspections
37
Sites
33
Observations
11
Career since
Jan 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| AIT Biosciences | 28 Mar 2025 | Human Drugs | |
| Charles River Laboratories Ashland, LLC | 14 Feb 2025 | Human Drugs | |
| Celerion Inc | 17 Jan 2025 | Human Drugs | |
| Smithers Pharmaceutical Development Services | 13 Dec 2024 | Human Drugs | |
| Pharmaron (Exton) Lab Services LLC | 27 Sep 2024 | Human Drugs |
Sites inspected
AIT BiosciencesIndianapolis, United States1 insp.
Charles River Laboratories Ashland, LLCAshland, United States1 insp.
Celerion IncLincoln, United States1 insp.
Smithers Pharmaceutical Development ServicesGaithersburg, United States1 insp.
Pharmaron (Exton) Lab Services LLCExton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Yiyue C Zhang6 shared
Joseph L Despins2 shared
Craig A Garmendia2 shared
Zhou Chen2 shared
Ruben C Ayala2 shared
Vickie J Kanion2 shared
D'Arbra R Blankenship1 shared
Brittany L Carpenter1 shared
Brandy D Brown1 shared
Stephanie C Mangigian1 shared
Full investigator report
Get the verbatim findings behind Yiyue Zhang's 11 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site